In vivo class II transactivator expression in mice is induced by a non- interferon-γ mechanism in response to local injury

Transplantation

Volumn 64, Issue 12, 1997, Pages 1657-1664

  Sims, Tasha N ^a   Goes, Nelson B ^a,b   Ramassar, Vido ^a   Urmson, Joan ^a   Halloran, Philip F ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GENTAMICIN; INTERFERON REGULATORY FACTOR 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; STAT1 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; CONFERENCE PAPER; CONTROLLED STUDY; GENE EXPRESSION; ISCHEMIA; MOUSE; NEPHROTOXICITY; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE INJURY; TRANSACTIVATION; TRANSCRIPTION INITIATION;

ANIMALS; DNA-BINDING PROTEINS; GENE EXPRESSION; GENES, MHC CLASS II; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERFERON REGULATORY FACTOR-1; INTERFERON TYPE II; KIDNEY; KIDNEY DISEASES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NUCLEAR PROTEINS; PHOSPHOPROTEINS; RNA, MESSENGER; TIME FACTORS; TRANS-ACTIVATORS;

EID: 0031449665     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199712270-00005     Document Type: Conference Paper

References (59)

1. Halloran PF, Homik J, Goes N, et al. The "injury response": a concept linking non-specific injury, acute rejection, and long term transplant outcomes. Transplant Proc 1997; 29: 79.
2. Shoskes DA, Halloran PF. Delayed graft function in renal transplantation: etiology, management and long-term significance. J Urol 1996; 155: 1831.
3. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995; 333: 333.
4. Mach B, Steimle V, Martinez-Soria E, Reith W. Regulation of MHC class II genes: lessons from a disease. Annu Rev Immunol 1996; 14: 301.
5. Steimle V, Otten LA, Zufferey M, Mach B. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or Bare Lymphocyte Syndrome). Cell 1993; 75: 135.
6. Reith W, Steimle V, Mach B. Molecular defects in the bare lymphocyte syndrome and regulation of MHC class II genes. Immunol Today 1995; 16: 539.
7. Steimle V, Durand B, Barras E, et al. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev 1995; 9: 1021.
8. Chang C-H, Guerder S, Hong S-C, van Ewijk W, Flavell RA. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 1996; 4: 167.
9. Mach B. MHC class II regulation: lessons from a disease. N Engl J Med 1995; 332: 120.
10. Silacci P, Mottet A, Steimle V, Reith W, Mach B. Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA. J Exp Med 1994; 180: 1329.
11. Steimle V, Siegrist CA, Mottet A, Lisowska-Grospierre B, Mach B. Regulation of MHC class II expression by interferon-γ mediated by the transactivator gene CIITA. Science 1994; 265: 106.
12. Chang CH, Fontes JD, Peterlin M, Flavell RA. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J Exp Med 1994; 180: 1367.
13. Chin KC, Mao C, Skinner C, et al. Molecular analysis of G1B and G3A IFNγ mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction. Immunity 1994; 1: 687.
14. Sims TN, Elliott JF, Ramassar V, Denney DW Jr, Halloran PF. Mouse CIITA: cDNA sequence and amino acid comparison with human CIITA. Immunogenetics 1997; 45: 220.
15. Ramassar V, Goes N, Hobart M, Halloran PF. Evidence for the in vivo role of class II transactivator in basal and IFN-γ induced class II expression in mouse tissue. Transplantation 1996; 62: 1901.
16. k antigens in tissue of nonlymphoid origin. Immunogenetics 1981; 14: 359.
17. a complex expression causes a corresponding defect in antigen presentation. J Exp Med 1982; 155: 508.
18. a complex. J Exp Med 1982; 155: 490.
19. Matis LA, Glimcher LH, Paul WE, Schwartz RH. Magnitude of response of histocompatibility-restricted T-cell clones is a function of the product of the concentrations of antigen and Ia molecules. Proc Natl Acad Sci USA 1983; 80: 6019.
20. Hobart M, Ramassar V, Goes N, Urmson J, Halloran PF. Interferon regulatory factor 1 (IRF-1) plays a central role in the regulation of the expression of class I and II major histocompatibility complex genes in vivo. J Immunol 1997; 158: 4260.
21. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 1993; 259: 1739.
22. Goes N, Sims T, Urmson J, Vincent D, Ramassar V, Halloran PF. Disturbed MHC regulation in the interferon-γ knockout mouse. J Immunol 1995; 155: 4559.
23. Shoskes D, Parfrey NA, Halloran PF. Increased major histocompatibility complex antigen expression in unilateral ischemic acute tubular necrosis in the mouse. Transplantation 1990; 49: 201.
24. Goes N, Urmson J, Ramassar V, Halloran PF. Ischemic acute tubular necrosis induces an extensive local cytokine response: evidence for induction of interferon-γ, transforming growth factor β-1, granulocyte-macrophage colony-stimulating factor, interleukin-2 and interleukin-10. Transplantation 1995; 59: 565.
25. Salacinski PRP, McLean C, Sykes JEC, Clements-Jones VV, Lowry PJ. Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3,6-diphenyl Glycoluril (Iodogen). Anal Biochem 1981; 117: 136.
26. Jephthah-Ochola J, Urmson J, Farkas S, Halloran PF. Regulation of MHC in vivo: bacterial lipopolysaccharide induces class I and II MHC products in mouse tissues by a T cell independent, cyclosporine sensitive mechanism. J Immunol 1988; 141: 792.
27. Cockfield SM, Ramassar V, Urmson J, Halloran PF. Multiple low dose streptozotocin induces systemic MHC expression in mice by triggering T cells to release IFN-γ. J Immunol 1989; 142: 1120.
28. Halloran PF, Urmson J, Ramassar V, Laskin C, Autenried P. Increased class I and class II MHC products and mRNA in kidneys of MRL-lpr/lpr mice during autoimmune nephritis and inhibition by cyclosporine. J Immunol 1988; 141: 2303.
29. Chirgwin JM, Pryzybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294.
30. Halloran PF, Autenried P, Ramassar V, Urmson J, Cockfield S. Local T cell responses induce widespread MHC expression: evidence that IFN-γ induces its own expression in remote sites. J Immunol 1992; 148: 3837.
31. Goes N, Urmson J, Vincent D, Ramassar V, Halloran PF. Induction of major histocompatibility complex and inflammatory cytokines after ischemic injury to the kidney: lessons from the interferon-γ gene knockout mice. Transplant Proc 1995; 27: 771.
32. Lennon A-M, Ottone C, Rigaud G, et al. Isolation of a B-cell-specific promoter for the human class II transactivator. Immunogenetics 1997; 45: 266.
33. Matsuyama T, Kimura T, Kitagawa M, et al. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 1993; 75: 83.
34. Miyamoto M, Fujita T, Kimura Y, et al. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-β gene regulatory elements. Cell 1988; 54: 903.
35. Briken V, Ruffner H, Schultz U, et al. Interferon regulatory factor 1 is required for mouse Gbp gene activation by gamma interferon. Mol Cell Biol 1995; 15: 975.
36. Lew DJ, Decker T, Strehlow I, Darnell JE. Overlapping elements in the guanylate-binding protein gene promoter mediate transcriptional induction by α and γ interferons. Mol Cell Biol 1991; 11: 182.
37. Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994; 264: 1415.
38. Sadowski HB, Shuai K, Darnell JE Jr, Gilman MZ. A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science 1993; 261: 1739.
39. Shuai K, Ziemiecki A, Wilks AF, et al. Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins. Nature 1993; 366: 580.
40. Shuai K, Stark GR, Kerr IM, Darnell JE Jr. A single phosphotyrosine residue of Stat91 required for gene activation by interferon-γ. Science 1993; 261: 1744.
41. Decker T, Lew DJ, Mirkovitch J, Darnell JE Jr. Cytoplasmic activation of GAF, an IFN-γ-regulated DNA-binding factor. EMBO J 1991; 10: 927.
42. Müller M, Briscoe J, Laxton C, et al. The protein tyrosine kinase JAK1 complements defects in interferon-α/β and -γ signal transduction. Nature 1993; 366: 129.
43. Watling D, Guschin D, Müller M, et al. Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-γ signal transduction pathway. Nature 1993; 366: 166.
44. Riley JL, Westerheide SD, Price JA, Brown JA, Boss JM. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). Immunity 1995; 2: 533.
45. Abdulkadir SA, Ono SJ. How are class II MHC genes turned on and off? FASEB J 1995; 9: 1429.
46. Lee Y-J, Benveniste EN. Stat1α expression is involved in IFN-γ induction of the class II transactivator and class II MHC genes. J Immunol 1996; 157: 1559.
47. Glimcher LH, Kara CJ. Sequences and factors: a guide to MHC class-II transcription. Annu Rev Immunol 1992; 10: 13.
48. Benoist C, Mathis D. Regulation of major histocompatibility complex class II genes: X, Y and other letters of the alphabet. Annu Rev Immunol 1990; 8: 681.
49. Finn PW, Kara CJ, Douhan J III, Van TT, Folsom V, Glimcher LH. Interferon γ regulates binding of two nuclear protein complexes in a macrophage cell line. Proc Natl Acad Sci USA 1990; 87; 914.
50. Kern I, Steimle V, Siegrist C-A, Mach B. The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genes. Int Immunol 1995; 7: 1295.
51. Chang C-H, Flavell RA. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J Exp Med 1995; 181: 765.
52. Lu L, Woo J, Rao AS, et al. Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen. J Exp Med 1994; 179: 1823.
53. Rohn WM, Lee Y-J, Benveniste EN. Regulation of class II MHC expression. Crit Rev Immunol 1996; 16: 311.
54. Safirstein RL, Bonventre JV. Molecular response to ischemic and nephrotoxic acute renal failure. In: Schlöndorff D, Bonventre JV, eds. Molecular nephrology: kidney function in health and disease. New York: Marcel Dekker, Inc., 1995: 839.
55. Safirstein R. Gene expression in nephrotoxic and ischemic acute renal failure. J Am Soc Nephrol 1994; 4: 1387.
56. Goes N, Hobart M, Ramassar V, Urmson J, Halloran PF. Many forms of renal injury induce a stereotyped response with increased expression of MHC, IFN-γ and adhesion molecules. Transplant Proc 1997; 29: 1085.
57. Goes N, Urmson J, Vincent D, Halloran PF. Acute renal injury in the interferon-gamma knockout mouse: effect on cytokine gene expression. Transplantation 1995; 60: 1560.
58. Hobart M, Ramassar V, Goes N, Urmson J, Halloran PF. The induction of class I and II major histocompatibility complex by allogeneic stimulation is dependent on the transcription factor interferon regulatory factor 1 (IRF-1): observations in IRF-1 knockout mice. Transplantation 1996; 62: 1895.
59. Halloran PF. Rethinking immunosuppression in terms of the redundant and nonredundant steps in the immune response. Transplant Proc 1996; 28: 11.